Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Higher-dose statins raise risk for osteoporosis

The higher the dosage of cholesterol-lowering statins, the greater a patient’s risk of developing osteoporosis, according to work published in the Annals of Rheumatic Diseases.

Thumbnail

CVS halts all sales of Zantac, store-brand ranitidine

CVS Pharmacy announced Sept. 28 it would be suspending the sales of all Zantac-brand and CVS Health-brand ranitidine products until further notice, pending the results of an FDA investigation.

3-year COAPT results bolster MitraClip’s success

Results from the COAPT study continue to roll in, and it was all positive news for the MitraClip team at the TCT conference in San Francisco this month.

Thumbnail

Frequent, persistent hot flashes predict later CVD events

Frequent and persistent hot flashes during menopause can majorly raise women’s risk of clinical CVD events in the following 20 years, researchers reported at the 30th Annual Meeting of the North American Menopause Society.

FDA greenlights early feasibility study for less-invasive TMVR system

Medtronic announced Sept. 27 that it had received FDA approval to launch an early feasibility study for its Intrepid TMVR system using a minimally invasive transfemoral access approach.

Thumbnail

Bootleg cannabis pens found to contain vitamin E, pesticides

Tests commissioned by NBC News have revealed that vitamin E—the suspected culprit behind some 800-plus reported cases of vaping-related lung illness—is present in many THC cartridges sold on the black market, alongside other toxicities like pesticides and myclobutanil.

Thumbnail

Shorter-duration DAPT looks favorable for patients at a high risk of bleeding after PCI

A shortened, three-month course of dual antiplatelet therapy might be a safer bet than 12-month treatment for patients at a high risk of bleeding after PCI and implantation of a drug-eluting stent.

Thumbnail

Robocath completes 1st in-human robotic angioplasties

French company Robocath announced Sept. 24 it had successfully completed its first two in-human coronary angioplasties performed with assistance from its R-One robotic platform.